Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis

Primary melanoma aggressiveness is determined by rapid selection and growth of cellular clones resistant to conventional treatments, resulting in metastasis and recurrence. In addition, a reprogrammed tumor-immune microenvironment supports melanoma progression and response to therapy. There is an ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Negrea, Giorgiana, Rauca, Valentin-Florian, Meszaros, Marta Szilvia, Patras, Laura, Luput, Lavinia, Licarete, Emilia, Toma, Vlad-Alexandru, Porfire, Alina, Muntean, Dana, Sesarman, Alina, Banciu, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016200/
https://www.ncbi.nlm.nih.gov/pubmed/35450036
http://dx.doi.org/10.3389/fphar.2022.870347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016200/
https://www.ncbi.nlm.nih.gov/pubmed/35450036
http://dx.doi.org/10.3389/fphar.2022.870347

Ejemplares similares